GET /api/ms_vocab/?format=api&offset=13420&ordering=-name
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 43797,
    "next": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=13440&ordering=-name",
    "previous": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=13400&ordering=-name",
    "results": [
        {
            "accession": "CLO:0007675",
            "name": "MEL-HO cell",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007674",
            "name": "MELC DS19 cell",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007673",
            "name": "MELC DR10 cell",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007672",
            "name": "MELC cell",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0042470",
            "name": "melanosome",
            "definition": "['A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:1909",
            "name": "melanoma",
            "definition": "['A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from melanocytes which are found in skin, the bowel and the eye.']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:191",
            "name": "melanocytic neoplasm",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0036160",
            "name": "melanocyte-stimulating hormone secretion",
            "definition": "['The regulated release of a melanocyte-stimulating hormone, any of a group of peptide hormones that are produced by cells in the intermediate lobe of the pituitary gland, and stimulate the production of melanin to increase pigmentation.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000440",
            "name": "melanocyte stimulating hormone secreting cell",
            "definition": "['A cell of the intermediate pituitary that produces melanocyte stimulating hormone.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000148",
            "name": "melanocyte",
            "definition": "['A pigment cell derived from the neural crest. Contains melanin-filled pigment granules, which gives a brown to black appearance.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000541",
            "name": "melanoblast",
            "definition": "['A cell that originates from the neural crest and differentiates into a pigment cell.', 'Derived from UBERON:0002342 neural crest.']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007671",
            "name": "MEL-14 cell",
            "definition": "['disease: hybridoma']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007655",
            "name": "Me Jon cell",
            "definition": "['disease: osteogenesis imperfecta (congenita)']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0140013",
            "name": "meiotic nuclear division",
            "definition": "['One of the two nuclear divisions that occur as part of the meiotic cell cycle.']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:1903046",
            "name": "meiotic cell cycle process",
            "definition": "['A process that is part of the meiotic cell cycle.']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0051321",
            "name": "meiotic cell cycle",
            "definition": "['Progression through the phases of the meiotic cell cycle, in which canonically a cell replicates to produce four offspring with half the chromosomal content of the progenitor cell via two nuclear divisions.', \"Note that this term should not be confused with 'GO:0140013 ; meiotic nuclear division'. 'GO:0051321 ; meiotic cell cycle represents the entire mitotic cell cycle, while 'GO:0140013 meiotic nuclear division' specifically represents the actual nuclear division step of the mitotic cell cycle.\"]",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0061983",
            "name": "meiosis II cell cycle process",
            "definition": "['A process that coontributes to the second meiotic division. The second meiotic division separates chromatids resulting in a haploid number of chromosomes.']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0007135",
            "name": "meiosis II",
            "definition": "['The second nuclear division of meiosis, in which the two chromatids in each chromosome are separated, resulting in four daughter nuclei from the two nuclei produced in meiosis II.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000553",
            "name": "megakaryocyte progenitor cell",
            "definition": "['The earliest cytologically identifiable precursor in the thrombocytic series. This cell is capable of endomitosis and lacks expression of hematopoieitic lineage markers (lin-negative).', 'Lineage negative is described here as CD2-negative, CD3-negative, CD4-negative, CD5-negative, CD8a-negative, CD14-negative, CD19-negative, CD20-negative, CD56-negative, Ly6g-negative, and Ter119-negative.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000050",
            "name": "megakaryocyte-erythroid progenitor cell",
            "definition": "['A progenitor cell committed to the megakaryocyte and erythroid lineages.', 'MEPs are reportedly CD19-negative, CD34-negative, CD45RA-negative, CD110-positive, CD117-positive, and SCA1-negative and reportedly express the transcription factors GATA-1 and NF-E2.']",
            "term_type": "cell line"
        }
    ]
}